AFL · NYSE
Aflac Incorporated
$120.51 -2.77 (-2.25%)
Company overview
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments: Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
- Sector
- Financial Services
- Industry
- Insurance - Life
- Exchange
- NYSE
- Market cap
- $60.4B
- Employees
- 12,694
- Headquarters
- Columbus, GA
- Website
- aflac.com
- CEO
- Daniel Paul Amos
- Listed
- March 17, 1980
- P/E
- 13.69
- Dividend yield
- 2.07%
Company financials
- Revenue
- $18.2B
- Gross profit
- $8.7B
- Operating income
- $5.6B
- EBITDA
- $6.7B
- Net income
- $4.6B
- EPS
- $8.80
- Total assets
- $120B
- Total debt
- $7.8B
- Gross margin
- 47.76%
- Net margin
- 25.44%
- Earnings yield
- 7.30%
Showing FY 2025
AFL
1D
NYSE
O120.70H123.28L120.56C123.27+3.12 (+2.60%)Vol1.24M